Key result
Pre-existing ICD status is not independently associated with in-hospital mortality.
Why the study?
Hospitalizations for heart failure with reduced ejection fraction complicated by cardiac arrest represent a high-risk population, and the role of a pre-existing implantable cardioverter-defibrillator in these patients remained unclear.
Does a pre-existing implantable cardioverter-defibrillator reduce in-hospital mortality in adult hospitalizations for heart failure with reduced ejection fraction complicated by cardiac arrest?
Observational (n=11,945)
Yes
Does a pre-existing implantable cardioverter-defibrillator reduce in-hospital mortality in adult hospitalizations for heart failure with reduced ejection fraction complicated by cardiac arrest?
In adult hospitalizations for HFrEF complicated by cardiac arrest, pre-existing ICDs were uncommon (4.6%) and were not independently associated with in-hospital mortality after adjusting for baseline comorbidities and clinical severity.
Answers are grounded in this paper and cite their sources.
Pre-existing ICD status should not alter acute management in HFrEF arrest; leaves open independent effects in prospective cohorts.
Background: Hospitalizations for heart failure with reduced ejection fraction complicated by cardiac arrest represent a high-risk population, and the role of a pre-existing implantable cardioverter-defibrillator in these patients remains unclear. Methods: We conducted a retrospective observational study using the National Inpatient Sample from 2016 through 2022. Adult hospitalizations (age 18 years or older) with heart failure with reduced ejection fraction and cardiac arrest were identified using diagnosis codes. Pre-existing defibrillator status was defined by a code indicating a device present before admission. Outcomes were compared by device status using survey-weighted methods, and a multivariable logistic regression model evaluated the independent association between device status and in-hospital mortality, adjusting for demographics, comorbidities, and clinical severity. Results: Among 11,945 weighted hospitalizations, 545 (4.6%) had a documented pre-existing defibrillator. Crude in-hospital mortality was higher among hospitalizations with a device than those without (21.1% vs 9.7%, P<0.01). After adjustment, device status was not independently associated with in-hospital mortality (adjusted odds ratio 1.34, 95% confidence interval 0.63 to 2.84). Do-not-resuscitate status (adjusted odds ratio 15.56) and cardiogenic shock (adjusted odds ratio 1.47) were strongly associated with higher mortality. Conclusions: In this national sample, pre-existing defibrillators were uncommon. Although crude mortality was higher among patients with a device, device status was not independently associated with in-hospital mortality after adjustment, suggesting outcomes were driven primarily by baseline risk and clinical severity. Studies incorporating arrest rhythm, timing, and device interrogation are needed to clarify mechanisms and optimize post-arrest management.
No takes yet. Share an insight, caveat, or question.
Sivakumar et al. (2026) conducted an observational in Heart failure with reduced ejection fraction complicated by cardiac arrest (n=11,945). Pre-existing implantable cardioverter-defibrillator (ICD) vs. No pre-existing implantable cardioverter-defibrillator was evaluated on In-hospital mortality (OR 1.34, 95% CI 0.63-2.84, p=0.45). Pre-existing ICD status was not independently associated with in-hospital mortality despite higher crude mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: